These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12090700)

  • 1. Childhood-onset growth hormone deficiency: reassessment of GH status after completion of growth.
    Charmian AQ
    Int J Clin Pract Suppl; 2002 May; (126):8-13. PubMed ID: 12090700
    [No Abstract]   [Full Text] [Related]  

  • 2. The consequences of discontinuing GH after linear growth is completed.
    Bengtsson BA; Johannsson G
    Int J Clin Pract Suppl; 2002 May; (126):22-6. PubMed ID: 12090696
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of GH replacement in young patients with childhood onset GH deficiency.
    Christiansen JS; Vahl N; Nørrelund H; Jørgensen JO
    Int J Clin Pract Suppl; 2002 May; (126):32-6. PubMed ID: 12090699
    [No Abstract]   [Full Text] [Related]  

  • 4. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
    Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
    Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M; Smyczynska J; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment.
    Wu KH; Tsai FJ; Peng CT
    Ann Hematol; 2003 Oct; 82(10):637-40. PubMed ID: 12898188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirming the diagnosis of growth hormone deficiency (GHD) and transitioning the care of patients with childhood-onset GHD.
    Hintz RL
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():631-5. PubMed ID: 12795365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy.
    Ham JN; Ginsberg JP; Hendell CD; Moshang T
    Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ghrelin in weight gain and growth in epileptic children using valproate.
    Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S
    J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition of childhood-onset growth hormone-deficient patients to adult healthcare.
    Rapaport R; Cook DM
    Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():82-90. PubMed ID: 17261975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
    Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is final height the only target of paediatric human growth hormone treatment?
    Clayton PE
    Int J Clin Pract Suppl; 2002 May; (126):3-7. PubMed ID: 12090698
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW; Willemsen RH; van der Kaay DC; Duivenvoorden HJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual aspects of GH re-testing.
    Lissett CA
    Int J Clin Pract Suppl; 2002 May; (126):14-7. PubMed ID: 12090694
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.